FAQs

Investors

FREQUENTLY ASKED QUESTIONS

You'll Find Answers Here!

  • When was Curative Biotechnologies Inc. founded?

    Curative Biotechnology, Inc., (CTYX) formerly known as ConnectyxTechnologies Holding Group, Inc. (CTYX) was founded in 2007. New management assumed control in February 2020.The Company changed the name and trading symbol in the first quarter of 2021.

  • Where is the Company headquartered?

    Curative Biotech is headquartered at:
    1825 NW Corporate Blvd., Suite 110
    Boca Raton, FL 33431

  • What exchange do Curative Biotech shares trade on?

    Curative Biotech shares currently trade on the OTC Markets Group under the symbol “CTYX” for common shares.

  • Does Curative Biotech offer a direct stock purchase program?

    Curative Biotech does not offer a direct stock purchase program.

  • When does the Curative Biotech fiscal year end?

    Curative Biotech’s fiscal year ends on December 31.

  • How can I obtain Curative Biotech OTC filings?

    Curative Biotech OTC filings, including its annual report, quarterly earnings releases and other investor materials are available under the “Investors” section of our corporate website.

    Additionally, all OTC filings can also be accessed directly from the OTC Markets website at: Filings and Disclosure

  • Does Curative Biotech plan to pay a cash dividend?

    Curative Biotech does not anticipate paying any cash dividends in the foreseeable future.

  • Who is Curative Biotech’s transfer agent?

    The transfer agent and registrar for Curative Biotech is:

    Issuer Direct Corporation,
    500 Perimeter Park Drive, Suite D,
    Morrisville, NC 27560.
    919-481-4000
    www.issuerdirect.com

  • How do I contact Investor Relations?